Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Journey Medical Corp (DERM)
NASDAQ:DERM
DERM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.85 - $6.89
Previous CloseN/A
Volume25.59K
Average Volume (3M)56.06K
Market Cap
$107.37M
Enterprise Value$114.65M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Mar 20, 2025EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.92
Shares Outstanding14,889,936
10 Day Avg. Volume52,876
30 Day Avg. Volume56,063
Standard Deviation0.20
R-Squared0.07
Alpha-0.00460
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.86
Price to Cash Flow (P/CF)-23.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.18
Enterprise Value/Ebitda-8.84
Forecast
1Y Price Target
$10.00Price Target Upside100.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Journey Medical Corp News
PremiumCompany Announcements
Journey Medical Reports Q3 2024 Earnings, Eyes Emrosi Launch
---
Bulls Say, Bears Say
Bulls Say
Market PositioningDFD-29 is expected to be well-positioned to drive substantial long-term growth based on its superior data compared to Oracea.
Product LaunchThe company expects a full commercial launch in early April, following the availability of the launch product and a national sales meeting.
Revenue GrowthThe approval and launch of DFD-29 into the rosacea market is expected to drive substantial revenue growth.
Bears Say
Pricing StrategyThe company disclosed a $1,298 WAC for Emrosi pricing compared to Oracea's $914 WAC, clearly indicating the superiority of Emrosi's clinical data.
Stock DeclineShares are down 18% since the end of 2023 and have been down as much as 49% over the year.
Stock PerformanceShares have traded down 14% since the product’s approval in November and are now valued at a 55% discount to peers on a 2026 EV/revenue basis.
---
Ownership Overview
45.26% Insiders
2.81% Mutual Funds
13.38% Other Institutional Investors
36.22% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DERM FAQ
What was Journey Medical Corp’s price range in the past 12 months?
Journey Medical Corp lowest stock price was $2.85 and its highest was $6.89 in the past 12 months.
What is Journey Medical Corp’s market cap?
Journey Medical Corp’s market cap is $107.37M.
When is Journey Medical Corp’s upcoming earnings report date?
Journey Medical Corp’s upcoming earnings report date is Mar 20, 2025 which is in 27 days.
How were Journey Medical Corp’s earnings last quarter?
Journey Medical Corp released its earnings results on Nov 12, 2024. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.17 by $0.05.
Is Journey Medical Corp overvalued?
According to Wall Street analysts Journey Medical Corp’s price is currently Undervalued.
Does Journey Medical Corp pay dividends?
Journey Medical Corp does not currently pay dividends.
What is Journey Medical Corp’s EPS estimate?
Journey Medical Corp’s EPS estimate is -0.2.
How many shares outstanding does Journey Medical Corp have?
Journey Medical Corp has 14,889,936 shares outstanding.
What happened to Journey Medical Corp’s price movement after its last earnings report?
Journey Medical Corp reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.17. Following the earnings report the stock price went down -6.055%.
Which hedge fund is a major shareholder of Journey Medical Corp?
Among the largest hedge funds holding Journey Medical Corp’s share is Royce & Associates LLC. It holds Journey Medical Corp’s shares valued at 0.
---
Journey Medical Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (100.80% Upside)
$10.00 (100.80% Upside)
Hedge Fund Trend
Decreased
By 12.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 9.8%
Last 30 Days ▼ 9.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.90%
12-Months-Change
Fundamentals
Return on Equity
-129.58%
Trailing 12-Months
Asset Growth
-2.84%
Trailing 12-Months
Company Description
Journey Medical Corp
Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model.
---
DERM Stock 12 Month Forecast
Average Price Target
$10.00
▲(100.80% Upside)
Technical Analysis
Best Analysts Covering DERM
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
+20.84%
reiterated a buy rating 4 months ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +20.84% per trade.
---